Skip to main content
Year archive

ABL Bio Inc. — 2022 filings

All 65 regulatory filings released by ABL Bio Inc. (298380) in 2022, sourced directly from the official regulator.

65 Filings
2022 Period
2022 filings (65)
Filing Released Lang
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-12-27 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-12-20 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-12 Korean
투자판단관련주요경영사항(이중항체 파킨슨병 치료제 ABL301의 미국 FDA 제1상 임상시험계획 (IND) 결과 - Partial Clinical Hold)
Legal Proceedings Report
2022-12-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-12-09 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-11-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-11-21 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
투자판단관련주요경영사항(이중항체 파킨슨병 치료제 ABL301의 미국 FDA 제1상 임상시험계획 (IND) 변경 신청)
Legal Proceedings Report
2022-11-07 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-10-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-10-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-10-11 Korean
투자판단관련주요경영사항(이중항체 파킨슨병 치료제 ABL301의 미국 FDA 제1상 임상시험계획 (IND) 신청)
Regulatory Filings
2022-10-04 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-09-30 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-09-30 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-09-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-09-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-09-28 Korean
투자판단관련주요경영사항(ABL301 관련 마일스톤 기술료 수령)
Regulatory Filings
2022-09-15 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-08-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-08-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-08-12 Korean
[기재정정]사업보고서 (2021.12)
Annual Report FY 2021
2022-08-12 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-08-05 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-07-20 Korean
투자판단관련주요경영사항(ABL202 관련 마일스톤 기술료 배분)
Regulatory Filings
2022-07-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-07-01 Korean
투자판단관련주요경영사항(ABL001 관련 마일스톤 기술료 수령)
Regulatory Filings
2022-06-27 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-06-02 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-05-31 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-05-24 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-05-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-05-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-05-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-04-14 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-03-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-30 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-03-30 Korean
투자판단관련주요경영사항(이중항체 항암제 ABL001의 제1b상 임상시험 결과)
Legal Proceedings Report
2022-03-29 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-03-15 Korean
주주총회소집결의
AGM Information
2022-03-15 Korean
주주총회집중일개최사유신고
AGM Information
2022-03-15 Korean
사업보고서 (2021.12)
Annual Report FY 2021
2022-03-15 Korean
주주총회소집공고
AGM Information
2022-03-15 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-15 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-03-11 Korean
투자판단관련주요경영사항(ABL301 기술이전 및 공동개발 계약에 따른 계약금 수령)
Regulatory Filings
2022-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-11 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-02-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-01-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-01-21 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-01-14 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-01-13 Korean
투자판단관련주요경영사항(ABL301 기술이전 및 공동개발 계약 체결)
M&A Activity
2022-01-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-01-03 Korean